BGI Genomics Co., Ltd. (SHE:300676)
China
· Delayed Price · Currency is CNY 40.30
+0.02 (0.05%)
Apr 29, 2026, 3:04 PM CST
BGI Genomics Revenue
BGI Genomics had revenue of 808.65M CNY in the quarter ending March 31, 2026, with 20.35% growth. This brings the company's revenue in the last twelve months to 3.84B, up 3.35% year-over-year. In the year 2025, BGI Genomics had annual revenue of 3.71B, down -4.18%.
Revenue (ttm)
3.84B
Revenue Growth
+3.35%
P/S Ratio
4.02
Revenue / Employee
1.07M
Employees
3,580
Market Cap
15.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.71B | -161.54M | -4.18% |
| Dec 31, 2024 | 3.87B | -482.72M | -11.10% |
| Dec 31, 2023 | 4.35B | -2.70B | -38.33% |
| Jan 1, 2023 | 7.05B | 287.01M | 4.24% |
| Jan 1, 2022 | 6.77B | -1.63B | -19.42% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangzhou Kingmed Diagnostics Group | 5.91B |
| Dian Diagnostics Group | 10.10B |
| Amoy Diagnostics | 1.20B |
| Joinn Laboratories(China)Co.,Ltd. | 1.66B |
| Shanghai Runda Medical Technology | 7.40B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Cowealth Medical China | 656.38M |